US6130271A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Deformable absorbable surgical device
Assignee: JOHNSON BANK
•
Filing: 1998-01-09
•
Granted: 2000-10-10
•
Expires: 2018-01-09
Abstract
Abstract A deformable surgical repair device is manufactured from a block or graft copolymer. The copolymer comprises a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages. The plurality of first linkages comprises at least about 50 up to about 90 mole percent of the copolymer. In an alternative Claim, the deformable surgical repair device is manufactured from a blend of a first and a second absorbable polymer. The first absorbable polymer comprises a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof. The second absorbable polymer comprises a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages. The first absorbable polymer comprises at least about 50 up to about 90 weight percent of the blend. The device is useful in fracture fixation.
Inventors
- 👤 Peter Kendrick Jarrett
- 👤 Donald James Casey
- 👤 Steven L. Peake
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 18:15
CPC Classifications
A; A61; A61F; A61F5/00; A61L; A61L31/00; A61L31/14; A61L31/148; A61B; A61B17/00; A61B17/064; A61L31/04; A61L31/041; A61L31/06; A61L31/12; A61L31/125; A61L31/129; A61B17/0644; A61B17/56; A61B17/58; A61B17/68; A61B17/72; A61B17/80; A61B17/84; A61B17/86; A61B2017/00004
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
226 words
A surgical composite structure for mammalian tissue comprising: (a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a biocompatible polymer, and (b) a permanently deformable at ambient temperature bioabsorbable component consolidated around said plurality of fibers to form a matrix, the bioabsorbable component having a flexural strain at break of greater than about 25% and a flexural strain at yield of greater than about 3%; the bioabsorbable component comprising (i) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50up to about 90 weight percent of the blend, or (2) a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 2
Dependent Claim
226 words
A surgical composite structure for mammalian tissue comprising: (a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a biocompatible polymer, and (b) a permanently deformable at ambient temperature bioabsorbable component consolidated around said plurality of fibers to form a matrix, the bioabsorbable component having a flexural strain at break of greater than about 25% and a flexural strain at yield of greater than about 3%; the bioabsorbable component comprising (i) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50up to about 90 weight percent of the blend, or (2) a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 3
Dependent Claim
201 words
A surgical composite structure for mammalian tissue comprising: a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a bioabsorbable polymer, and b) a deformable at ambient temperature bioabsorbable component consolidated around said plurality of fibers to form a matrix, the bioabsorbable component comprising (1) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend, or (2) a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 4
Dependent Claim
201 words
A surgical composite structure for mammalian tissue comprising: a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a bioabsorbable polymer, and b) a deformable at ambient temperature bioabsorbable component consolidated around said plurality of fibers to form a matrix, the bioabsorbable component comprising (1) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend, or (2) a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 5
Dependent Claim
151 words
A surgical composite structure for mammalian tissue comprising: (a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a biocompatible polymer, and (b) a permanently deformable at ambient temperature bioabsorbable component consolidated around said plurality of fibers to form a matrix, the bioabsorbable component having a flexural strain at break of greater than about 25% and a flexural strain at yield of greater than about 3%; the bioabsorbable component comprising (i) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend.
Claim 6
Dependent Claim
151 words
A surgical composite structure for mammalian tissue comprising: (a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a biocompatible polymer, and (b) a permanently deformable at ambient temperature bioabsorbable component consolidated around said plurality of fibers to form a matrix, the bioabsorbable component having a flexural strain at break of greater than about 25% and a flexural strain at yield of greater than about 3%; the bioabsorbable component comprising (i) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend.
Claim 7
Dependent Claim
116 words
A surgical composite structure for mammalian tissue comprising: a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a bioabsorbable polymer, and b) a bioabsorbable matrix consolidated around the plurality of fibers, the bioabsorbable matrix comprising a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend.
Claim 8
Dependent Claim
116 words
A surgical composite structure for mammalian tissue comprising: a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a bioabsorbable polymer, and b) a bioabsorbable matrix consolidated around the plurality of fibers, the bioabsorbable matrix comprising a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend.
Claim 9
Dependent Claim
193 words
A surgical composite structure for mammalian tissue comprising: (a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a bioabsorbable polymer, and (b) a bioabsorbable matrix consolidated around the plurality of fibers, the bioabsorbable matrix comprising (1) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend, or (2) a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 10
Dependent Claim
193 words
A surgical composite structure for mammalian tissue comprising: (a) a reinforcing component prepared from a plurality of fibers, the plurality of fibers manufactured from a bioabsorbable polymer, and (b) a bioabsorbable matrix consolidated around the plurality of fibers, the bioabsorbable matrix comprising (1) a blend of a first and second absorbable polymer, the first absorbable polymer comprising a plurality of linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and the second absorbable polymer comprising a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the first absorbable polymer comprising at least about 50 up to about 90 weight percent of the blend, or (2) a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid ester linkages, and mixtures thereof, and a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one; 1,4-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 11
Dependent Claim
171 words
An article of manufacture comprising an absorbable surgical fastener manufactured from: a polymer blend composition containing: (a) a first absorbable polymer including a plurality of linkages selected from the group consisting of glycolic acid ester linkages, lactic acid ester linkages and mixtures thereof; and (b) a second absorbable polymer including a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one and e-caprolactone linkages, the first absorbable polymer being present in the blend in an amount from at least about 50 weight percent up to about 99 weight percent based on the total weight of the blend a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising: (a) a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid linkages, and mixtures thereof, and (b) a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 12
Dependent Claim
171 words
An article of manufacture comprising an absorbable surgical fastener manufactured from: a polymer blend composition containing: (a) a first absorbable polymer including a plurality of linkages selected from the group consisting of glycolic acid ester linkages, lactic acid ester linkages and mixtures thereof; and (b) a second absorbable polymer including a plurality of linkages selected from the group consisting of 1,3-dioxan-2-one and e-caprolactone linkages, the first absorbable polymer being present in the blend in an amount from at least about 50 weight percent up to about 99 weight percent based on the total weight of the blend a copolymer selected from the group consisting of a block and graft copolymer, the copolymer comprising: (a) a plurality of first linkages selected from the group consisting of glycolic acid ester and lactic acid linkages, and mixtures thereof, and (b) a plurality of second linkages selected from the group consisting of 1,3-dioxan-2-one and ε-caprolactone linkages, the plurality of first linkages comprising at least about 50 up to about 90 mole percent of the copolymer.
Claim 13
Dependent Claim
19 words
The surgical composite structure of claim 1 in which the plurality of fibers are manufactured from a bioabsorbable polymer.
References Cited (Backward Citations)
US4052988A
Cited
US4300565A
Cited
US4279249A
Cited
US4243775A
Cited
US4429080A
Cited
US4539981A
Cited
US4550449A
Cited
WO1984003035A1
Cited
US4655777A
Cited
EP0185453A2
Cited
US4646741A
Cited
US4923470A
Cited
US4743257C1
Cited
US4743257A
Cited
US4744365A
Cited
US4839130A
Cited
US4781183A
Cited
US4711241A
Cited
US4705820A
Cited
US4788979A
Cited
US4844854A
Cited
WO1989005664A1
Cited
US4916193A
Cited
US4920203A
Cited
US4916207A
Cited
US4891263A
Cited
US5080665A
Cited
US5324307A
Cited
US5376102A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-10-10 | 2004-04-10 | 2004-10-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-10-10 | 2008-04-10 | 2008-10-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-10-10 | 2012-04-10 | 2012-10-10 | $7700.00 | Window Closed / Lapsed |